NEW YORK (GenomeWeb News) – CombiMatrix said today that it has entered into an agreement with Stratose to provide coverage for its menu of diagnostic laboratory services, including its CombiSNP chromosomal microarray test.
Atlanta-based Stratose maintains a large preferred provider organization network in the US, including more than 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts. Members of these plans will now have access to CombiMatrix's suite of tests for use in prenatal, miscarriage, and pediatric healthcare.
CombiMatrix has announced agreements with a number of organizations to expand access to its services this year. In March, it partnered with American Pathology Partners to offer its microarray-based miscarriage testing service, and in January, it contracted with Galaxy Health Network to provide coverage of its tests for Galaxy's 3.5 million covered lives.